Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
APO866 in Advanced Melanoma
NCT00432107Phase 2Completed
- Sponsor
- Valerio Therapeutics
- Start
- Jul 2006
- Primary completion
- Feb 2008
- Modality
- Small Molecules
- Countries
- 4
01
Overview
A Phase 2 trial of daporinad in melanoma, sponsored by Valerio Therapeutics. Started Jul 2006; status: completed.
02
Drugs
daporinad
03
Conditions
melanoma
Beyond the preview
Go deeper on NCT00432107.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00432107.